PUBLISHER: IMARC | PRODUCT CODE: 1468319
PUBLISHER: IMARC | PRODUCT CODE: 1468319
The global advanced wound care market size reached US$ 10.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.27% during 2024-2032.
Advanced wound care is a standard medical solution that provides specialized treatment for chronic infections and non-healing wounds by removing dead and inflamed tissues. It includes medications, equipment, and several products that help treat acute and chronic wounds, such as burns, ulcers, and post-operative wounds. Advanced wound care products comprising silver and alginates are extensively used to remove excess fluids from wounds and protect them from infections. They include hydrogels, hydrocolloids, film and foam dressings, and alginates. They help retain skin moisture and facilitate quick healing of wounds internally and externally by promoting the growth of body cells.
The increasing global geriatric population and the rising prevalence of pressure ulcers, diabetic foot ulcers, and other chronic wounds are among the key factors positively influencing the market. Chronic wounds are complex and non-healing infections that fail to progress through the healing phases in an orderly sequence. In addition, the increasing occurrence of diabetes, obesity, and a significant surge in the need for surgical procedures across the globe are catalyzing the demand for advanced wound care products as they help absorb necrotic tissues, which are highly effective in the rapid healing of surgical site infections. In line with this, the rising awareness among individuals about the proven benefits and effectiveness of these products is increasing their sales worldwide. Apart from this, technological advancements in advanced wound care products are contributing to market growth. For instance, nanoparticle-based wound healing and skin regeneration bioactive molecules over the applied area maintain the drug release and improve the therapeutic effects of drugs. Furthermore, the expansion of Ambulatory Surgical Centers (ASCs) that provide diagnostics, preventive procedures, and surgical care for pain management, orthopedics, urology, restorative, organ transplantation, and reconstructive surgeries, is propelling the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global advanced wound care market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
Infection Management
Silver Wound Dressings
Non-silver Dressings
Collagen Dressings
Exudate Management
Hydrocolloids Dressings
Foam Dressings
Alginate Dressings
Hydrogel Dressings
Active Wound Care
Skin Substitutes
Growth Factors
Therapy Devices
Negative Pressure Wound Therapy (NPWT)
Oxygen and Hyperbaric Oxygen Equipment
Electromagnetic Therapy Devices
Others
Chronic Wounds
Pressure Ulcers
Diabetic Foot Ulcers
Venous Leg Ulcers
Arterial Ulcers
Acute Wounds
Burns and Trauma
Surgical Wounds
Hospitals
Community Health Service Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, B. Braun SE (B. Braun Holding GmbH & Co. KG), Cardinal Health, Inc., Coloplast A/S, Convatec Group plc, Essity AB, Integra LifeSciences, Medline Industries, LP, Medtronic plc, Molnlycke Health Care (Investor AB), Organogenesis Holdings Inc. and Smith & Nephew plc.